Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flemming Bendtsen

Showing results (61-70 of 259) with videos related to

Pageof 26
Sort By:
European Journal of Clinical Investigation|January 31, 2014
New vasoactive peptides in cirrhosis: organ extraction and relation to the vasodilatory stateNina Kimer, Jens Peter Goetze, Flemming Bendtsen, et al.
Journal of Hepatology|December 17, 2011
Betablockers induce cardiac chronotropic incompetenceAleksander Krag, Søren Møller, Andrew K Burroughs, et al.
International Journal of Cardiology|October 9, 2012
New insights into cirrhotic cardiomyopathySøren Møller, Jens D Hove, Ulrik Dixen, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 3, 2013
Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised studyLise Hobolth, Flemming Bendtsen, Erik F Hansen, et al.
Nature Reviews. Gastroenterology & Hepatology|November 13, 2013
Cirrhotic cardiomyopathy: pathogenesis and clinical relevanceSigne Wiese, Jens D Hove, Flemming Bendtsen, et al.
Ugeskrift for Laeger|August 7, 2014
[Cirrhosis of the liver]Flemming Bendtsen, Fin Stolze Larsen, Peter Ott, et al.
Journal of Crohn'S & Colitis|June 16, 2026
Medical and surgical therapies for patients with inflammatory bowel diseases and prior or coexisting cancer: a Danish nationwide cohort studyJonathan Plovgaard, Mads Damsgaard Wewer, Flemming Bendtsen, et al.
Lancet (London, England)|October 22, 2002
Effect of acetylcysteine on prothrombin index in paracetamol poisoning without hepatocellular injuryLars E Schmidt, Tore Tveit Knudsen, Kim Dalhoff, et al.
European Journal of Gastroenterology & Hepatology|March 15, 2011
Effects of treatment with β-blocker and aldosterone antagonist on central and peripheral haemodynamics and oxygenation in cirrhosisChristine Winkler, Lise Hobolth, Aleksander Krag, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 26, 2009
Reply to de Vries HE, Van Oijen MGH, de Jong DJ. Safety of infliximab in inflammatory bowel disease needs to be debated. Clin Gastroenterol Hepatol 2009;7:603-604Sarah Caspersen, Christian Mortensen, Lene Riis, et al.
Pageof 26

Showing results (61-70 of 259) with videos related to

Sort By:
Pageof 26
European Journal of Clinical Investigation|January 31, 2014
New vasoactive peptides in cirrhosis: organ extraction and relation to the vasodilatory stateNina Kimer, Jens Peter Goetze, Flemming Bendtsen, et al.
Journal of Hepatology|December 17, 2011
Betablockers induce cardiac chronotropic incompetenceAleksander Krag, Søren Møller, Andrew K Burroughs, et al.
International Journal of Cardiology|October 9, 2012
New insights into cirrhotic cardiomyopathySøren Møller, Jens D Hove, Ulrik Dixen, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 3, 2013
Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised studyLise Hobolth, Flemming Bendtsen, Erik F Hansen, et al.
Nature Reviews. Gastroenterology & Hepatology|November 13, 2013
Cirrhotic cardiomyopathy: pathogenesis and clinical relevanceSigne Wiese, Jens D Hove, Flemming Bendtsen, et al.
Ugeskrift for Laeger|August 7, 2014
[Cirrhosis of the liver]Flemming Bendtsen, Fin Stolze Larsen, Peter Ott, et al.
Journal of Crohn'S & Colitis|June 16, 2026
Medical and surgical therapies for patients with inflammatory bowel diseases and prior or coexisting cancer: a Danish nationwide cohort studyJonathan Plovgaard, Mads Damsgaard Wewer, Flemming Bendtsen, et al.
Lancet (London, England)|October 22, 2002
Effect of acetylcysteine on prothrombin index in paracetamol poisoning without hepatocellular injuryLars E Schmidt, Tore Tveit Knudsen, Kim Dalhoff, et al.
European Journal of Gastroenterology & Hepatology|March 15, 2011
Effects of treatment with β-blocker and aldosterone antagonist on central and peripheral haemodynamics and oxygenation in cirrhosisChristine Winkler, Lise Hobolth, Aleksander Krag, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 26, 2009
Reply to de Vries HE, Van Oijen MGH, de Jong DJ. Safety of infliximab in inflammatory bowel disease needs to be debated. Clin Gastroenterol Hepatol 2009;7:603-604Sarah Caspersen, Christian Mortensen, Lene Riis, et al.
Pageof 26